Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará;Reações adversas em pacientes com doença de Chagas tratados com benzonidazol, no Estado do Ceará

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 2, 2010, Pages 182-187

  de Pontes, Vânia Maria Oliveira ^a   de Souza Júnior, Alcidésio Sales ^a   da Cruz, Francisco Marcondes Tavares ^b   Coelho, Helena Lutéscia Luna ^a   Dias, Aparecida Tiemi Nagao ^a   Coêlho, Ivo Castelo Branco ^a   de Fátima Oliveira, Maria ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Walter Cantídio Univ Hosp   (Brazil)

Author keywords

Adverse reactions to drugs; Benznidazole; Chagas disease; Trypanosoma cruzi

Indexed keywords

AMINOTRANSFERASE; BENZNIDAZOLE;

ADULT; ADVERSE DRUG REACTION; AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD SAMPLING; BRAZIL; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DESCRIPTIVE RESEARCH; DRUG ERUPTION; DRUG FEVER; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTERVIEW; LABORATORY TEST; MALE; MUSCLE WEAKNESS; NAUSEA; NEUROTOXICITY; PARESTHESIA; PROSPECTIVE STUDY; PRURITUS; SIDE EFFECT; SKIN TINGLING; SKIN TOXICITY; VOMITING;

TRYPANOSOMA CRUZI;

EID: 77953980888     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000200015     Document Type: Article

References (28)

1. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends in Parasitology 2006; 22:583-588.
2. Dias JCP, Coura JR. Epidemiologia. In: Dias JCP, Coura JR, editores. Clínica e terapêutica da doença de chagas: uma abordagem prática para o clínico geral. Rio de Janeiro: FIOCRUZ; 1997. p. 33-66.
3. Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long- term follow-up. Am Heart J 1994; 127:151-162.
4. World Health Organization (WHO). Disponível em http://www.who.int/tdr/dw/chagas2003.htm. Acessado em 14/01/2005.
5. Oliveira MF, Nagao-Dias AT, Pontes VMO, Souza-Júnior AS, Coelho HLL, Coelho ICB. Tratamento Etiológico da Doença de Chagas no Brasil. Rev Pat Trop 2008; 37:209-228.
6. Coura JR, Abreu LL, Willcox HPF, Petana W. Estudo comparativo controlado com emprego de benznidazole, nifurtimox e placebo, na forma crônica da doença de Chagas, em uma área de campo com transmissão interrompida. I. Avaliação preliminar. Rev Soc Bras Med Trop 1997; 30:139-144.
7. Cançado JR. Long term evaluation of etiological treatment of Chagas' disease with benznidazole. Rev Inst Med Trop São Paulo 2002; 44:29-37.
8. Castro JA, Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas'disease (American Trypanosomíasis). Hum Exp Toxicol 2006; 25: 471-479.
9. Gontijo ED, Galvão LMC, Eloi-Santos S. Chagas Disease: Criteria of Cure and Prognosis. Mem Inst Oswaldo Cruz 2009; 94:357-362.
10. Viotti R, Vigliano C, Lococo B, Bertocch G, Petti M, Alvarez MG, Postan M, armenti A. Long-term cardiac outcomes of treating chronic Chagas disease winth benznidazole versus no treatment. Annals of Internal Medicine. 144:724-734, 2006.
11. Ministério da Saúde. Consenso Brasileiro em Doença de Chagas. Rev Soc Bras Med Trop 2005; 38 (supl 3):1-29.
12. Castro JA. Contribuition of toxicology to the problem of Chagas' disease (American Trypanosomíasis). A year 2000 update. Biom Environme Sciences 2000; 13:271-279.
13. Dias JCP. The treatment of Chagas disease (South American Trypanosomiasis). Annals of Internal Medicine 2006b; 144:772-774.
14. Organización Mundial de la Salud. El monitoreo de la seguridad de los productos medicinales: guía para el establecimiento y funcionamiento de Centros de Farmacovigilância. Buenos Aires; 1997.
15. World Health Organization (WHO). Adverse reaction terminology. Uppsala: The Uppsala Monitoring Centre, 1995.
16. Pfaffenbach G, Carvalho OM, Mendes GB. Reações adversas a medicamento da como determinantes admissão hospitalar. Rev Assoc Med Bras 2002; 48:237-241.
17. Silveira CAN, Castillo E, Castro C. Avaliação do tratamento específico para o Trypanosoma cruzi em crianças na evolução da fase indeterminada. Rev Soc Bras Med Trop 2000; 33:191-196.
18. Fabbro DL, Streiger ML, Arias ED, Bizai ML, Barco MDEL, Amicone NA. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 2007; 40:1-10.
19. Garcia S, Ramos CO, Senra JFV, Vilasboas F, Rodrigues MM, Campos DE et al. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antim Agents Chemoth 2005; 49: 1521-1528.
20. Andrade ALSS, Zickerf F, Oliveira RM, Silva AS, Luquetti A, Travassos LR, et al. Randomised trial of efficacy of benzonidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348:1407-1413.
21. Coura JR, Castro SL. A critical review on Chagas'disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:3-24.
22. Sosa-Estani S, Armenti A, Araújo G, Viotti R, Lococo B, Ruiz Vera B, Vigliano C, De Rissio AM, Segura EL. Tratamiento de la enfermedad de Chagas con benznidazol y ácido tioctico. Medicina (Buenos Aires) 2004; 64:1-6.
23. Ferreira HO. Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benzonidazol. Rev Soc Bras Med Trop 1990; 23:209-211.
24. Andrade AL, Martelli CM, Oliveira RM, Silva SA, Aires AI, Soussumi L M et al. Short report: Benznidazole efficacy among. Trypanosoma cruzi infected adolescents after a six year follow - up. Am J Trop Med Hyg 2004; 71:594-597.
25. Sosa-Estani S, Segura E, Ruiz AM, Velásquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Amer J Trop Med Hygiene 1998; 59:526-529.
26. Fabbro-Suasnábar D, Arias E, Streiger M, Placenza M, Ingaramo M, Del Barco M, Amiconé N. Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Rev. Inst Med Trop São Paulo 2000; 42:99-109.
27. Levi GC, Lobo IMF, Kallás EG, Amato Neto V. Etiological drug treatment of human infection by Trypanosoma cruzi. Rev Inst Med Trop S Paulo 1996; 38:35-38.
28. Meneghelli UG. Enteropatia chagásica. Rev Soc Bras Med Trop 2004; 37: 252-260.